Temporary Concerns Present Entry Point in Zoetis (ZTS)

1 hour ago 1

Soumya Eswaran

Thu, July 23, 2026 astatine 9:34 AM CDT 3 min read

Moon Capital Management, LLC, an concern absorption company, released its 2nd 4th 2025 capitalist letter. A transcript of the missive tin beryllium downloaded here. The S&P 500 scale rebounded successful the 2nd quarter, achieving a 9.6% instrumentality for the archetypal fractional of the year, portion Moon Capital Management's equity portfolio gained 4%. AI-related stocks led marketplace performance, mitigating geopolitical concerns. Moon Capital holds 10% of its portfolio successful technology, importantly little than the S&P 500's 39%. The steadfast remains cautious astir ample AI investments and their imaginable instrumentality connected investment. In addition, delight cheque the Strategy's apical 5 holdings to cognize its champion picks successful 2026.

In its Q2 2026 capitalist letter, Moon Capital Management highlighted Zoetis Inc. (NYSE:ZTS) arsenic a recently added position. Zoetis Inc. (NYSE:ZTS) is an carnal wellness institution focused connected carnal wellness medications, vaccines, and diagnostic products. On July 22, 2026, Zoetis Inc. (NYSE:ZTS) closed astatine $74.19 per share. One-month instrumentality of Zoetis Inc. (NYSE:ZTS) was -4.66%, and its shares mislaid 51.45% implicit the past 52 weeks. Zoetis Inc. (NYSE:ZTS) has a marketplace capitalization of $31.1 billion.

Moon Capital Management stated the pursuing regarding Zoetis Inc. (NYSE:ZTS) successful its Q2 2026 capitalist update:

"We added 1 caller banal to the portfolio past quarter, Zoetis Inc. (NYSE:ZTS). (Our mean acquisition terms was astir $73.20/share.) Zoetis is the world's largest pure-play carnal wellness company. We person agelong viewed Zoetis arsenic 1 of the highest-quality businesses successful healthcare (albeit for mostly 4 legged patients), and the institution has mostly been valued accordingly. However, impermanent concerns astir slower companion carnal maturation and accrued competitory pressures created an accidental to acquisition the institution astatine an charismatic price. After trading supra 30 times net for overmuch of the past decade, Zoetis present has a P/E of little than 11x, a valuation we judge importantly understates the quality, durability, and semipermanent net powerfulness of the business.

The carnal wellness manufacture is charismatic arsenic it combines the antiaircraft characteristics of healthcare investing with a much favorable manufacture operation than accepted pharmaceuticals. In opposition to quality healthcare, a important information of carnal wellness spending is paid straight by owners, which reduces reimbursement pressure. The manufacture besides benefits from little probe and improvement costs, shorter improvement timelines, and beardown relationships with veterinarians. These relationships, combined with regulatory barriers and specialized method expertise, make meaningful switching costs and lend to agelong merchandise lifecycles..." (Click present to work the afloat text)

Read Entire Article